Under the Affordable Care Act, most private health insurance plans are required to cover birth control methods approved by the FDA without out-of-pocket costs. But not all plans are doing this, Bernie Sanders declared in a letter.
Singling out an industry segment won’t solve the underlying problem of healthcare costs.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
Advocates of "Medicare for All" like Bernie Sanders underestimate the significant challenges to its implementation while ignoring or dismissing alternative models that achieve the same goal: equitable healthcare access for all.
Marathon Pharmaceuticals is doing some backtracking after the public, the media and now Bernie Sanders objected to the list price of its upcycled corticosteroid for Duchenne muscular dystrophy.
Bernie Sanders appeared on Real Time with Bill Maher to charge that Big Pharma spends more money on marketing and advertising than on research and development. Was he right?
A universal healthcare ballot measure is the latest in a series of cutting edge policy change proposals put in front of Colorado voters. But will it get the support of residents that recreational marijuana did?
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
The movement to save Lakewood Hospital outside Cleveland seems misguided.
Vermont Sen. Bernie Sanders released details of his "Medicare for all" single-payer healthcare proposal about two hours before the debate, perhaps fueling renewed interest in the Democratic race.
How stressed does Hillary Clinton get when talking about Wall Street or gun control?
Also, a new song from ZDogg, Baidu is in trouble for its medical claims and LifeWatch gets a new FDA clearance.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Theranos founder Elizabeth Holmes has moved to limit its fingerprick blood test vials after being forced on the defensive over its technology claims.